# Effect of the Plasma EBV DNA Change During Chemoradiotherapy in Nasopharyngeal Carcinoma

> **NCT03087695** · — · UNKNOWN · sponsor: **Taichung Veterans General Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

- **DIAGNOSTIC_TEST:** Plasma EBV DNA

## Key facts

- **NCT ID:** NCT03087695
- **Lead sponsor:** Taichung Veterans General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-04-01
- **Primary completion:** 2018-01-16
- **Final completion:** 2019-01-16
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2017-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03087695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03087695, "Effect of the Plasma EBV DNA Change During Chemoradiotherapy in Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03087695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*